NCT02028650View on ClinicalTrials.gov

Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched Transplantation

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

February 28, 2013

Study Completion Date

October 31, 2014

Conditions
Relapse Leukemia
Interventions
BIOLOGICAL

the first donor's stem cell

HLA-matched stem cell infusion

BIOLOGICAL

the second donor's stem cell

HLA-mismatched, the second donor's stem cell infusion

Trial Locations (1)

100071

Affiliated Hospital of Academy of Military Medical Sciences, Beijing

All Listed Sponsors
lead

huishengai

OTHER

NCT02028650 - Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched Transplantation | Biotech Hunter | Biotech Hunter